D70.1 Agranulocytosis secondary to cancer chemotherapy Notes: code for adverse effect, if applicable, to identify drug (T45.1X…

Agranulocytosis secondary to cancer chemotherapy
Notes: code for adverse effect, if applicable, to identify drug (T45.1X5)

Share

Comments are closed.